Quantum Biosystems

Quantum Biosystems is a Japanese biotechnology company developing a revolutionary single-molecule DNA and RNA sequencing platform. The company's core technology utilizes quantum tunneling to identify individual nucleotides as they pass through a nanogap electrode, eliminating the need for chemical labeling or amplification. This approach aims to provide high-speed, low-cost, and long-read sequencing capabilities for applications in personalized medicine and clinical diagnostics. By directly reading the electronic signature of molecules, Quantum Biosystems seeks to transform the landscape of genomic analysis. The company is headquartered in Osaka, Japan, with additional operations in the United States.